Beyond Air Inc. (XAIR)
XAIR trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1641631/000149315226030287/0001493152-26-030287-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-31.
Profile
| Field | Value |
|---|---|
| Ticker | XAIR on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001641631 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $7.7M |
| Net income | -$33.2M |
| Operating income | -$29.0M |
| Net margin | -433.0% |
| Operating margin | -378.2% |
| Revenue growth | +107.3% |
| Cash | $6.7M |
| Total assets | $35.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-12 |
| Cash and burn | $5.4M cash; operating cash flow -$4.9M a quarter. | Report 2026-09-30 |
| Shares outstanding | 1,666,104 (2026-11-10); 8,009,488 a year earlier; 31,972,434 three years earlier. 1y figure adjusted for splits (1-for-20 overall); 3y figure adjusted for splits (1-for-400 overall). | Cover page 2026-11-10 |
| Reverse splits, 3 years | 2; latest 1-for-20 on 2026-07-13 | Source 2026-07-13 |
| Shelf and offerings, 12 months | 2 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-08-17 |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-04-10 |
| Auditor | WithumSmith+Brown, PC, East Brunswick, New Jersey, United States; changed auditors 1 time in 24 months | 8-K 4.01 2024-12-20 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $225K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2027 2026-09-30 | $2.3M | -$7.8M | -$5.6M | $5.4M | $58K | $8.2M | 10-Q 2026-11-12 |
| Q1 2027 2026-06-30 | $1.8M | -$7.9M | -$4.9M | $5.5M | $231K | $7.7M | 10-Q 2026-08-13 |
| Q4 2026 2026-03-31 | $1.9M | -$10.3M | -$4.9M | $6.7M | $802K | $7.7M | 10-K 2026-06-26 |
| Q3 2026 2025-12-31 | $2.2M | -$7.3M | -$4.2M | $6.6M | No debt tags | $6.9M | 10-Q 2026-02-13 |
| Q2 2026 2025-09-30 | $1.8M | -$7.9M | -$4.5M | $9.7M | No debt tags | $5.8M | 10-Q 2026-11-12 |
| Q1 2026 2025-06-30 | $1.8M | -$7.7M | -$4.5M | $5.0M | $233K | $4.8M | 10-Q 2026-08-13 |
| Q4 2025 2025-03-31 | $1.2M | -$8.0M | -$7.0M | $4.7M | $1.2M | $3.7M | 10-K 2026-06-26 |
| Q3 2025 2024-12-31 | $1.1M | -$13.0M | -$7.7M | $4.6M | $11.8M | $3.0M | 10-Q 2026-02-13 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-08-24 |
| Latest annual report | 10-K | 2026-06-26 |
| Latest quarterly / interim | 10-Q | 2026-11-12 |
| Latest current report | 8-K | 2026-11-13 |
| Latest proxy | DEFA14A | 2026-10-30 |
Source: SEC EDGAR submissions feed, 635 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.4% |
| 1 month | -2.7% |
| 3 months | -69.2% |
| Year to date | -85.3% |
| 1 year | -92.6% |
| From 52-week high | -95.1% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TNON | Tenon Medical Inc. | $1.33 | -5.32% | $3.6M |
| VVOS | Vivos Therapeutics Inc. | $0.0822 | -16.12% | $2.8M |
| IVF | INVO Fertility Inc. | $2.40 | -7.69% | $2.8M |
| NVNO | enVVeno Medical Corporation | $5.95 | -3.65% | $4.1M |
| ICCM | IceCure Medical Ltd. | $0.7601 | +4.12% | $2.6M |
| BJDX | Bluejay Diagnostics Inc. | $2.29 | -12.26% | $2.6M |
| SNOA | Sonoma Pharmaceuticals Inc. | $0.8802 | -19.25% | $4.5M |
| BDMD | Baird Medical Investment Holdings Ltd Ordinary Share | $0.1065 | +17.68% | $4.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier